Dual Power Value Growth Fund

Product Summary

Investment Objective
The Fund adopts a top-down strategy and determines the allocation ratio of fund assets to stocks, derivatives, bonds and cash based on a comprehensive analysis of macroeconomic, policy and securities market trends. Adopting a bottom-up strategy, with value and growth as the main line, value-based stocks that are within a relatively safe margin and have good cash dividends according to the selection of Soochow ’s value motivation evaluation system The dynamic evaluation system selects high-growth, excellent company quality and good growth stocks as investment targets.

Investment Scope
This hunbrid actively invests in the mainland Chinese Market. The target proportion of equity investment in the fund’s investment portfolio is 60%-95% of the fund’s assets, of bond investment is 0-35% of the fund’s assets, and of cash and other short-term financial instrument assets within one year of the total is not more than 5% of the fund’s net asset value.

View full prospectus (in Chinese)

Fund Facts

Fund Type

Risk Level*

Moderate

Minimum Investment

¥1000

Open Date

2006-12-15

Fund Manager

刘元海 Liu WanHai

Fund Custodian

Agricultural Bank of China

Fund Advisor

Soochow Asset Management Co., Ltd.

Annual Expense Ratio**

1.75%

Purchase Fee

1.5%

Redemption Fee

<1yr – 0.5%, 2yr – 0%

* More info on risk.

** Expense ratio amounts are already included in the return and daily value figures listed. More info on fees .

Current Price

Daily Price[post-content id=6953]
Daily Change[post-content id=6957]
Last Updated[post-content id=6116]

Asset Distribution

Stocks83.73%
Bonds0%
Cash & Short Term Debt16.27%
Total Fund Assets (¥)496,000,000
Date Reported:2020/09/31

Recent Performance

Time PeriodAverage Return
6 months[post-content id=6087]
YTD (year to date)[post-content id=4397]
1 year[post-content id=4401]
2 years[post-content id=4404]
Since inception[post-content id=4406]

Top 10 Holdings

Stock name (English)Stock name (Chinese)Portion of net worth
WuXi AppTec药明康德4.86%
China International Travel Service Corporation中国中免4.66%
King-Strong New Material新劲刚4.38%
SonoScape Medical Corp开立医疗3.98%
Luzhou Laojiao泸州老窖3.95%
Changzhou Xingyu星宇股份3.88%
East Money Information东方财富3.37%
Tellgen透景生命3.31%
BioKangtai康泰生物3.25%
Chongqing Zhifei智飞生物2.98%

Back to funds list